CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY - USD ($) $ in Thousands	Total	Cumulative Effect, Period of Adoption, Adjustment	Common stock	Additional paid-in capital	Additional paid-in capital Cumulative Effect, Period of Adoption, Adjustment	Retained earnings	Retained earnings Cumulative Effect, Period of Adoption, Adjustment	Accumulated other comprehensive loss
Beginning balance, common stock (in shares) at Dec. 31, 2020			44,346,630
Beginning balance at Dec. 31, 2020	$ 1,211,018		$ 443	$ 456,274		$ 809,107		$ (54,806)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income	496,714					496,714
Other comprehensive income, net of tax expense	$ (21,382)							(21,382)
Exercise of stock options (in shares)	70,776		70,776
Exercise of stock options	$ 2,939		$ 1	2,938
Issuance of restricted stock, net (in shares)			560,290
Issuance of restricted stock, net	0		$ 5	(5)
Issuance of shares under Employee Stock Purchase Plan (in shares)			109,248
Issuance of shares under employee stock purchase plan	9,231		$ 1	9,230
Repurchase and retirement of common stock (in shares)			(697,657)
Repurchase and retirement of common stock	(78,327)		$ (7)	(26,275)		(52,045)
Share-based compensation	25,248			25,248
Conversion shares issued as extinguishment cost on 3.25% convertible notes (in shares)			3,050,850
Conversion shares issued as extinguishment cost to redeem 3.25% Convertible Notes	431,952		$ 31	431,921
Redemption of 3.25% Convertible Notes, net of tax	(390,526)			(390,526)
Consensus separation	280,360					261,394		18,966
Other, net	505			317		188
Ending balance, common stock (in shares) at Dec. 31, 2021			47,440,137
Ending balance at Dec. 31, 2021	1,967,732	$ (64,701)	$ 474	509,122	$ (88,137)	1,515,358	$ 23,436	(57,222)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income	63,757					63,757
Other comprehensive income, net of tax expense	$ (32,207)			(206)		206		(32,207)
Exercise of stock options (in shares)	5,439		5,439
Exercise of stock options	$ 148			148
Issuance of restricted stock, net (in shares)			493,300
Issuance of restricted stock, net	(1)		$ 5	(6)
Issuance of shares under Employee Stock Purchase Plan (in shares)			139,992
Issuance of shares under employee stock purchase plan	9,431		$ 1	9,430
Repurchase and retirement of common stock (in shares)			(809,422)
Repurchase and retirement of common stock	(78,291)		$ (7)	(17,277)		(61,007)
Share-based compensation	26,601			26,601
Conversion shares issued as extinguishment cost to redeem 3.25% Convertible Notes	0
Redemption of 3.25% Convertible Notes, net of tax	0
Consensus separation								4,056
Other, net	$ 142			6		(3,920)		4,056
Ending balance, common stock (in shares) at Dec. 31, 2022	47,269,446		47,269,446
Ending balance at Dec. 31, 2022	$ 1,892,611		$ 473	439,681		1,537,830		(85,373)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income	41,503					41,503
Other comprehensive income, net of tax expense	$ 13,753							13,753
Exercise of stock options (in shares)	0
Issuance of restricted stock, net (in shares)			47,274
Issuance of restricted stock, net	$ (4,647)			(6,220)		1,573
Issuance of shares under Employee Stock Purchase Plan (in shares)			161,488
Issuance of shares under employee stock purchase plan	8,727		$ 2	8,725
Issuance of common stock, net (in shares)			186,102
Issuance of common stock, net	13,422		$ 2	13,420
Repurchase and retirement of common stock (in shares)			(1,585,846)
Repurchase and retirement of common stock	(104,919)		$ (16)	(15,388)		(89,515)
Share-based compensation	31,920			31,920
Conversion shares issued as extinguishment cost to redeem 3.25% Convertible Notes	0
Redemption of 3.25% Convertible Notes, net of tax	0
Other, net	$ 628			63		565		0
Ending balance, common stock (in shares) at Dec. 31, 2023	46,078,464		46,078,464
Ending balance at Dec. 31, 2023	$ 1,892,998		$ 461	$ 472,201		$ 1,491,956		$ (71,620)